The long QT syndrome: A review of recent molecular genetic and physiologic discoveries

Medicine

Volumn 75, Issue 1, 1996, Pages 1-5

  Keating, Mark T ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

CHROMOSOMAL LOCALIZATION; CHROMOSOME 11P; CHROMOSOME 3P; CHROMOSOME 7; GENE LOCUS; GENETIC LINKAGE; HUMAN; LONG QT SYNDROME; MEDICAL DECISION MAKING; PRIORITY JOURNAL; REVIEW;

CHROMOSOMES, HUMAN; ELECTROCARDIOGRAPHY; FEMALE; GENETIC MARKERS; HUMANS; LONG QT SYNDROME; MOLECULAR BIOLOGY; POINT MUTATION;

EID: 0030071326     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199601000-00001     Document Type: Review

References (21)

1. Benhorin J, Kalman YM, Medina A, Towbin J, Rave-Harel N, Dyer TD, Blangero J, MacCluer JW, Kerem B. Evidence of genetic heterogeneity in the long QT syndrome. Science 260: 1960-62, 1993.
2. Bennett PB, Yazawa K, Makita N, George AL. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376: 683-85, 1995.
3. Curran ME, Atkinson D, Timothy K, Vincent GM, Moss A, Leppert M, Keating MT. Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest 92: 799-803, 1993.
4. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80: 795-803, 1995.
5. Gura T. Estrogen: Key player in heart disease among women. Science 269: 771-73, 1995.
6. Jervell A, Lange-Nielsen F. Congenital deaf mutism, functional heart disease with prolongation of the QT interval, and sudden death. Am Heart J 54: 59-78, 1957.
7. Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, Timothy K, Taggart RT, Schwartz PJ, Vincent GM, Moss AJ, Keating MT. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet 8: 141-47, 1994.
8. Kadish AH, Morady F. Torsade de pointes. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: From cell to bedside. Philadelphia: WB Sanders, pp.605-10, 1995.
9. Kannel WB, Cupples A, D'Agostino RB. Sudden death risk in overt coronary heart diseases: The Framingham study. Am Heart J 113: 799-804, 1987.
10. Keating MT, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 252: 704-6, 1991.
11. Roden DM. Arrhythmogenic potential of class III antiarrhythmic agents: Comparison with class I agents. In: Singh BN, ed. Control of cardiac arrhythmias by lengthening repolarization. Mt. Kisco, NY: Futura, pp. 559-76, 1988.
12. Romano C. Congenital cardiac arrhythmia. Lancet 1: 658-59, 1965.
13. Roy N, Kahlem P, Dausse E, Bennaceur M, Faure S, Weissenbach J, Komajda M, Denjoy I, Coumel P, Schwartz K, Guicheney P. Exclusion of HRAS from long QT locus. Nat Genet 8: 113-14, 1994.
14. Kr potassium channel. Cell 81: 299-307, 1995.
15. Surawicz B. Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol 14: 172-84, 1989.
16. Towbin JA, Pagotto L, Sju B, Robinson J, Moss A, McCabe ERB, Heitmancik JF. Romano-Ward long QT syndrome (RWLQTS): Evidence of genetic heterogeneity [abstract]. Pediatr Res 31: 125a, 1992.
17. Vincent GM, Timothy KW, Leppert MF, Keating MT. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med 327: 846-52, 1992.
18. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80: 805-11, 1995.
19. Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc 54: 103-6, 1964.
20. Willich SN, Levy D, Rocco MB, Toner GH, Stone PH, Muller JOE. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol 60: 801-6, 1987.
21. Zipes DP. Proarrhythmic effects of antiarrhythmic drugs. Am J Cardiol 59: 26E-31E, 1987.